Paul Goeld

Paul Goeld is the founder and Executive Chairman of AEGEA Medical. He is also the Managing Director of Keystone Advisors, a firm that provides advisory services for early-stage medical device companies and private equity firms.

Paul has been a founder, CEO or Director of several medical device companies including CoAlign Innovations (acquired by Stryker), Adiana (acquired by Hologic), Pilot Cardiovascular (acquired by C. R. Bard), ESTECH (acquired by Atricure), General Surgical Innovations (public and acquired by Tyco), Camino Laboratories (now Integra Life Sciences) as well as private, venture-backed companies Relievant Medsystems, Gynesonics, Intuity Medical, Baronova, and Bioventrix.

Important Safety Information:

The Mara Water Vapor Ablation System is indicated to ablate the endometrial lining of the uterus in premenopausal women with menorrhagia due to benign causes for whom childbearing is complete. Pregnancy following the Mara procedure can be dangerous. The Mara procedure is not for those who have or suspect uterine cancer; have an active genital, urinary or pelvic infection; or an IUD. As with all surgical procedures, there are risks and considerations associated with the use of the Mara Water Vapor Ablation System. Please refer to the device labeling for a detailed discussion of the device’s intended use, relevant warnings, precautions, side effects, and contraindications.